Emercell is a biotech company bridging immunotherapy research projects to first pharmaceutical development steps
NK-001 Product & Technology
Emercell is developing off-the-shelf cell immunotherapy NK-based to be used in synergy with Monoclonal Antibodies (MAbs) to treat cancer. This new and innovative cell therapy called NK-001 consists of allogeneic Natural Killer (NK) cells derived from compatible pooled Umbilical Cord Blood (UCBs) activated & amplified ex vivo according to a patented process.
Contact
Information
Email : contact@emercell.com
Tél : +(33) 6.20.80.28.95
Head office
36 Chemin de l’hôpital
34270 St Mathieu de Tréviers
Laboratory
IRMB – CHRU de Montpellier
80 avenue Augustin Fliche
34295 Montpellier
Tel : +(33) 4.99.23.45.52
Mission
Emercell’s focus is to complete the pharmaceutical development of innovative cell therapy products, up to the clinical proof of concept
Immunotherapy and cell therapy are highly potent therapeutic ways to help body’s immune system and to better fit the current therapeutic needs
The first project of Emercell is NK-001, in oncology area
News & Events
Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy
Jun 20, 2022
Emercell Signs Strategic Partnership with Onward Therapeutics for the Development of its NK Cell Therapy Technology
Feb 17, 2021
Emercell NK-001 project selected as part of France 2030 plan “Biotherapies and bioproduction of innovative therapies"
Jul 24, 2023
Emercell and Cell-Easy Sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001
Sep 22, 2022
NK-001 Product & Technology
EMERCELL is developing off-the-shelf cell immunotherapy NK-based to be used in synergy with Monoclonal Antibodies (MAbs) to treat cancer. This new and innovative cell therapy called NK-001 consists of allogeneic Natural Killer (NK) cells derived from compatible pooled Umbilical Cord Blood (UCBs) activated & amplified ex vivo according to a patented process.
Pooled UCBs
Patented production process
Off the shelf frozen NK-001 cells
MAb + thawed NK-001 infusion
